KENYON ISAACS: Open Payments
NPI 1588178610 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 19 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $961 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $404 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Exact Sciences Corporation | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: FARXIGA, AIRSUPRA, BREZTRI, TRELEGY ELLIPTA, JARDIANCE, Cologuard Collection Kit, NEXLETOL, OTEZLA.
Industry payments across TX — which companies pay providers there.
